4893 items matching your search terms.

Maternal abdominal subcutaneous fat thickness as a predictor for adverse pregnancy outcome: a longitudinal cohort study

Kennedy, N. J. Peek, M. J. Quinton, A. E. Lanzarone, V. Martin, A. Benzie, R. Nanan, R.
BJOG, 2016     DOI:10.1111/1471-0528.13758

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

Kerr, R. S. Love, S. Segelov, E. Johnstone, E. Falcon, B. Hewett, P. Weaver, A. Church, D. Scudder, C. Pearson, S. Julier, P. Pezzella, F. Tomlinson, I. Domingo, E. Kerr, D. J.
LANCET ONCOLOGY, 2016     DOI:10.1016/S1470-2045(16)30172-3

Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus

Khalafallah, A. Phuah, E. Al-Barazan, A. M. Nikakis, I. Radford, A. Clarkson, W. Trevett, C. Brain, T. Gebski, V. Corbould, A.
BMJ OPEN, 2016     DOI:10.1136/bmjopen-2016-011059

Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy

Khasraw, M. Ananda, S. Michael, M.
EXPERT REVIEW OF ANTICANCER THERAPY, 2016     DOI:10.1586/14737140.2016.1146135

Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial

Khasraw, M. Lee, A. McCowatt, S. Kerestes, Z. Buyse, M. E. Back, M. Kichenadasse, G. Ackland, S. Wheeler, H.
JOURNAL OF NEURO-ONCOLOGY, 2016     DOI:10.1007/s11060-016-2094-0

VERTU: Veliparib, radiotherapy and temozolomide trial in unmethylated MGMT glioblastoma

Khasraw, M. McDonald, K.L. Rosenthal, M. Lwin, Z Ashley, D. Wheeler, H Barnes, E.H. Koh, E. S. Foote, M.C. Buckland, M. Swanson, R. Hall, M. Yip, S. Oostendorp, M. Simes, J.

Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin-bound paclitaxel in breast cancer

Khasraw, M. Mukaro, V.R. West, L. White, K. Rippy, E. Brandt, C. Tobler, R. Murphy, C.C. Collins, I.M. Baron-Hay, S.E. Ashley, D.M. Patil, S.

Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin-bound paclitaxel in breast cancer

Khasraw, M. Murphy, C. Mukaro, V.R. West, L. White, K. Brandt, C. Baron-Hay, S.E. Collins, I. Tobler, R. Ashley, D.M. Patil, S.

Osseointegrated total hip replacement connected to a lower limb prosthesis: a proof-of-concept study with three cases

Khemka, A. FarajAllah, C. I. Lord, S. J. Bosley, B. Al Muderis, M.
J ORTHOP SURG RES, 2016     DOI:10.1186/s13018-016-0348-3

Minimally invasive medial patellofemoral ligament reconstruction for patellar instability using an artificial ligament: A two year follow-up

Khemka, A. Lord, S. J. Doyle, Z. Bosley, B. Al Muderis, M.
KNEE, 2016     DOI:10.1016/j.knee.2015.07.002

A comparison of GP and specialist diabetes clinic based adult type 1 diabetes glucose self-care and control

Kilov, G. Januszewski, A.S. Larsson, C. Ludwigsson, J. MacIsaac, R Ward, G. O'Neal, D.N. Fulcher, G. McGrath, R. Jenkins, A.J.

Coxsackievirus B5 Infection Induces Dysregulation of microRNAs Predicted to Target Known Type 1 Diabetes Risk Genes in Human Pancreatic Islets

Kim, K. W. Ho, A. Alshabee-Akil, A. Hardikar, A. A. Kay, T. W. Rawlinson, W. D. Craig, M. E.
DIABETES, 2016     DOI:10.2337/db15-0956

Hypoxia tolerance in diabetes mellitus: the role of fenofibrate in facilitating protective metabolic reprogramming

King, E. Yuan, J. Kong, S. Dunn, L. Stocker, R. Keech, A. Jenkins, A. Ng, M.
, 2016     DOI:10.1016/j.hlc.2016.06.205

In science communication, why does the idea of a public deficit always return? How do the shifting information flows in healthcare affect the deficit model of science communication?

Ko, H.

A systematic review of performance enhancing biotechnological and pharmacological products for army to improve cognitive performance and decision-making

Ko, H. Hunter, K. Scott, A. M. Ayson, M. Marcal, H. Willson, M.